Browse Pet Safety Reports
8,562 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 8,562 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 8,562 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Dec 12, 2017 | Cat | Domestic Shorthair | Florfenicol; Terbinafine Hydrochlorid... | Application site pruritus; Application site dermatitis; Application site muco... | Outcome Unknown |
| Dec 12, 2017 | Dog | Coonhound (unspecified), Do... | Oclacitinib Maleate | Pododermatitis; Limping; Moist dermatitis; Pyoderma; Bacterial skin infection... | Ongoing |
| Dec 8, 2017 | Dog | Chihuahua | Cefovecin | Lethargy (see also Central nervous system depression in 'Neurological'); Anor... | Recovered/Normal |
| Dec 7, 2017 | Dog | Retriever - Labrador | Afoxolaner | Vomiting; Pododermatitis | Recovered/Normal |
| Dec 5, 2017 | Dog | Dog (unknown) | Oclacitinib Maleate | Hot spot (pyotraumatic dermatitis); Abscess NOS; INEFFECTIVE, ATOPY CONTROL | Outcome Unknown |
| Dec 5, 2017 | Cat | Domestic Shorthair | Cefovecin | Injection site lump; Injection site dermatitis; Licking | Ongoing |
| Dec 5, 2017 | Dog | Poodle - Toy | Selamectin | Application site itching; Application site alopecia; Application site erythem... | Outcome Unknown |
| Dec 3, 2017 | Dog | Collie (unspecified) | Grapiprant | Vomiting; Lameness; Skin abscess; Alopecia local; Dermatitis; Emesis (multiple) | Outcome Unknown |
| Dec 2, 2017 | Dog | Bichon Frise | Afoxolaner | Hot spot (pyotraumatic dermatitis); Pruritus; Hypoalbuminaemia; Hypoproteinaemia | Outcome Unknown |
| Dec 1, 2017 | Dog | Dog (unknown) | Spinosad | Hot spot (pyotraumatic dermatitis) | Ongoing |
| Dec 1, 2017 | Dog | Bullmastiff | Grapiprant | Lack of efficacy - NOS; Hot spot (pyotraumatic dermatitis) | Ongoing |
| Nov 29, 2017 | Cat | Domestic Longhair | Fluralaner Spot-On Solution | Moist dermatitis; Pruritus; Application site dermatitis; Application site pru... | Ongoing |
| Nov 26, 2017 | Dog | Havanese | Afoxolaner | Pinnal erythema; Oedematous erythema; Dermatitis | Recovered/Normal |
| Nov 22, 2017 | Dog | Pit Bull | Imidacloprid; Moxidectin | Rash; Skin lesion NOS; Dermatitis; Pyoderma; Alopecia | Outcome Unknown |
| Nov 22, 2017 | Dog | Pit Bull | Imidacloprid; Moxidectin | Skin lesion NOS; Dermatitis; Pyoderma; Alopecia local; Rash | Outcome Unknown |
| Nov 21, 2017 | Dog | Pit Bull | Spinosad; Milbemycin Oxime | External ear disorder NOS; Pyoderma; Pododermatitis; Allergy to food | Outcome Unknown |
| Nov 20, 2017 | Dog | Retriever - Flat-coated | Fluralaner Chew Tablets | Ear pruritus; Skin scab; Hot spot (pyotraumatic dermatitis); Skin sore; Ear d... | Ongoing |
| Nov 18, 2017 | Dog | Retriever - Labrador | Maropitant Citrate | Pinnae disorder; Hot spot (pyotraumatic dermatitis); Abnormal cytology | Recovered/Normal |
| Nov 17, 2017 | Dog | Terrier - Border | Rabacfosadine Succinate | Dermatitis; Alopecia; Emesis; Disorientation; Pain NOS; Shaking; Intervertebr... | Recovered/Normal |
| Nov 15, 2017 | Cat | Domestic Shorthair | Selamectin | Application site hot spot; Dermatitis; Dermal thickening; Hair change; Applic... | Ongoing |
| Nov 13, 2017 | Dog | Retriever - Labrador | Cyclosporine | Moist dermatitis; Gingival hyperplasia | Ongoing |
| Nov 9, 2017 | Dog | Retriever - Labrador | Oclacitinib Maleate | Skin disorders NOS; Pododermatitis | Ongoing |
| Nov 8, 2017 | Dog | Dog (unknown) | Toceranib Phosphate | Dermatitis | Outcome Unknown |
| Nov 4, 2017 | Dog | Beagle | Milbemycin Oxime; Praziquantel | Hot spot (pyotraumatic dermatitis); Vomiting | Outcome Unknown |
| Nov 2, 2017 | Dog | Retriever - Golden | Oclacitinib Maleate | Pododermatitis | Ongoing |
| Nov 1, 2017 | Dog | Mixed (Dog) | Afoxolaner | Erythema (for urticaria see Immune SOC); Skin disorders NOS; Dermatitis | Outcome Unknown |
| Oct 27, 2017 | Dog | Retriever - Golden | Rabacfosadine Succinate | Alopecia local; Dermatitis; Pyoderma; Erythema (for urticaria see Immune SOC)... | Outcome Unknown |
| Oct 25, 2017 | Dog | Bulldog - American | Fluralaner Chew Tablets | Rash; Moist dermatitis | Outcome Unknown |
| Oct 24, 2017 | Dog | Retriever - Golden, Poodle ... | Polysulfated Glycosaminoglycan | Loose stool; Low platelet count; Large platelets; Bloody diarrhoea; Rectal bl... | Ongoing |
| Oct 24, 2017 | Dog | Retriever - Labrador | Afoxolaner | Pruritus; Hair loss NOS; Ulcerative dermatitis | Outcome Unknown |
| Oct 22, 2017 | Cattle | Holstein-Friesian also know... | Cephapirin Sodium | Lameness; Dermatitis | Ongoing |
| Oct 22, 2017 | Cat | Domestic (unspecified) | Fluralaner Spot-On Solution | Behavioural disorder NOS; Rubbing; Application site hair loss; Discomfort NOS... | Ongoing |
| Oct 22, 2017 | Dog | Collie - Rough-haired | Grapiprant | Hot spot (pyotraumatic dermatitis) | Ongoing |
| Oct 20, 2017 | Dog | Retriever - Golden, Poodle ... | Milbemycin Oxime; Praziquantel | Lethargy (see also Central nervous system depression in 'Neurological'); Gagg... | Ongoing |
| Oct 17, 2017 | Dog | Shepherd Dog - Australian | Meloxicam | Ulcerative dermatitis | Outcome Unknown |
| Oct 15, 2017 | Dog | Maltese | Insulin Injectable Vial | Allergic dermatitis; Pyoderma; INEFFECTIVE, GLYCEMIC CONTROL; Wrong technique... | Outcome Unknown |
| Oct 14, 2017 | Dog | Cattle Dog - Australian (bl... | Polysulfated Glycosaminoglycan | Ulcerative dermatitis; Alopecia local | Recovered with Sequela |
| Oct 14, 2017 | Dog | Cattle Dog - Australian (bl... | Spinosad; Milbemycin Oxime | Ulcerative dermatitis; Alopecia local | Recovered with Sequela |
| Oct 14, 2017 | Dog | Bulldog | Grapiprant | Pododermatitis; Abnormal cytology; Suppurative dermatitis | Ongoing |
| Oct 14, 2017 | Dog | Shepherd Dog - German | Spinosad; Milbemycin Oxime | Itching; Hair loss NOS; Skin sore; Allergic dermatitis; Hives (see also 'Skin... | Outcome Unknown |
| Oct 11, 2017 | Dog | Retriever - Golden | Carprofen | Hot spot (pyotraumatic dermatitis) | Ongoing |
| Oct 11, 2017 | Cat | Domestic Shorthair | Cefovecin | Alopecia; Erythema (for urticaria see Immune SOC); Moist dermatitis; Lethargy... | Ongoing |
| Oct 10, 2017 | Dog | Retriever - Golden | Spinosad; Milbemycin Oxime | Anxiety; Dermatitis; Elevated alanine aminotransferase (ALT) | Outcome Unknown |
| Oct 9, 2017 | Cat | Domestic Shorthair | Cefovecin | Scratching; Flaking skin; Skin lesion NOS; Other abnormal test result NOS; Hy... | Outcome Unknown |
| Oct 5, 2017 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Itching; Reddening of the skin; Crust; Facial swelling (see also 'Skin'); Ulc... | Outcome Unknown |
| Oct 3, 2017 | Cat | Domestic Shorthair | Selamectin | Application site lesion; Application site scratching; Licking at application ... | Ongoing |
| Oct 2, 2017 | Dog | Terrier - Cairn | Meloxicam | Reluctant to move; Uncomfortable; Injection site swelling; Pain NOS; Hot spot... | Outcome Unknown |
| Oct 1, 2017 | Dog | Spaniel - Springer English | Fluralaner Chew Tablets | Vomiting; Diarrhoea; Polyuria; Lethargy (see also Central nervous system depr... | Outcome Unknown |
| Oct 1, 2017 | Dog | Retriever - Labrador | Spinosad; Milbemycin Oxime | Dermatitis | Ongoing |
| Oct 1, 2017 | Dog | Dog (unknown) | Spinosad; Milbemycin Oxime | Hot spot (pyotraumatic dermatitis) | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.